2025 Prix Galien Bridges Laureates

The inaugural Prix Galien Bridges yielded an impressive millesime.

dropdown-iconBest Bridge-Builder Institution

Coalition for Epidemic Preparedness Innovations (CEPI)

dropdown-iconBest Biotech & Pharma Product

QUVIVIQ - Idorsia Pharmaceuticals Nordics AB

dropdown-iconBest Medical Technology / AI Advances in Human Health

AI-Immunology™ platform - Evaxion

dropdown-iconBest Product for Rare/Orphan Diseases

VORANIGO® - Servier Pharmaceuticals

dropdown-iconBest Public Sector Innovation

MenAfriVac - PATH

Through the “Bridges” initiative, Prix Galien leverages its convening power to build and strengthen relationships that showcase the Nordic1 region’s long history of creative, integrated approaches to maximizing its reach and market potential in the larger regional/global biopharmaceutical and adjacent technology sectors.

Best Bridge-Builder 2025
Best Bridge-Builder Institution 2025 
Best BioPharma 2025
Best Biotech & Pharma Product 2025 
Best MedtechAI 2025
Best Medical Technology/AI Advances 2025 
Best RareOrphan 2025
Best Product for Rare/Orphan Diseases 2025 
Best Public Sector Innovation 2025
Best Public Sector Innovation 2025 

2025 «True North» Award

In addition to our competitive award categories for innovation and institutional excellence, Bridges features a special individual honor: The Bengt I. Samuelsson «True North» Award for scientific integrity.

This award recognizes scientists who pursue research with exceptional ethical rigor, intellectual honesty, and commitment to advancing knowledge without fanfare or self-promotion. The «True North» designation reflects the moral compass and unwavering scientific standards that guide the best research toward meaningful impact on human health. 

The 2025 Bengt I. Samuelsson "True North" Award for Scientific Integrity was presented to Jesper Z Haeggström, MD, PhD, Head of Division Chemistry II at the Karolinska Institutet’s Department of Medical Biochemistry and Biophysics in recognition of his commitment to ethical rigor, intellectual honesty, mentorship in is advancement of science.

True North Award 2025 -3
Karin Samulesson
True North Award 2025 -2
Jesper Z Haeggström, MD, PhD

An illustrious committee of industry leaders
Judges of the Prix Galien Bridges Awards are among the industry’s brightest luminaries from their respective countries. Respected globally, we are particularly excited to bring them together for the Prix Galien Bridges Awards where we anticipate particularly meaningful exchange through the prism of the geographical bridge they represent.

Maria Alonso Image
Professor of Pharmaceutical Technology, University of Santiago de Compostela
María José ALONSO, MD, PhD
Alon Chen Image
President, Weizmann Institute of Science
Alon CHEN, PhD
Mikael Dolsten Photo
Chair, Prix Galien Bridges Committee; Chairman, Quarry Thera (founding CEO), Orbis Medicine, Orogen Therapeutics, and Mast Cell Sciences Board member, Agilent Technologies, Rocket Pharmaceuticals, Chai Discovery, BenchSci, and Enveda Biosciences
Mikael DOLSTEN, MD, PhD
Emma Guttman Image
Chair, Kimberly & Eric J. Waldman Department of Dermatology, Icahn School of Medicine at Mount Sinai
Emma GUTTMAN-YASSKY, MD, PhD
Mirza Mansoor photo
Medical Director, Nordic Society of Gynaecologic Oncology-Clinical Trial Unit
Mansoor MIRZA, MD
Aarno Palotie Photo
Research Director of Human Genomics, Institute for Molecular Medicine Finland
Aarno PALOTIE, MD, PhD
Erik Renstrom Photo
Vice Chancellor, Lund University
Erik RENSTRÖM, PhD
John Arne Rottingen photo
CEO, Wellcome
John-Arne RØTTINGEN, MD, PhD
Veronika Sexl photo
Rector, University of Innsbruck
Veronika SEXL, MD, PhD
Kári Stefánsson Photo
CEO, deCODE genetics
Kári STEFANSSON, MD, PhD

Through a set of prestigious annual awards, unique, internal stakeholder dialogue, public events, and persuasive published research and communications, we will help make the case for innovative biopharma science as a driver of balanced development and for the transformative knowledge and business practices that add to quality of life for patients and more efficient use of scarce health resources. We recognize the importance of leveraging these strengths to enhance the science base in selected small and middle-sized markets that have yet to secure their potential in attracting the scalable investments necessary to bring new cures and treatments to a wider circle of patients.

Michael Dolsten

Prix Galien Bridges Committee Chair, Mikael Dosten at the Inaugural Awards Ceremony

We deliberately use the term “Bridges” given our aim to – through this initiative - facilitate expertise and knowledge transfers around the Nordic region’s innovation precedents and best practices with five additional strategic countries (comprising the plus in Nordics+): Austria, Israel, The Netherlands, Portugal, and Spain. Countries in the region with existing, active Prix Galien programs – Belgium, France, Germany, Greece, and Italy – have pledged their collaboration and solidarity.

Certain part of the world highlighting country in red colors

1 The Nordic countries are a geographical and cultural region in Northern Europe and the North Atlantic. It includes the sovereign states of Denmark, Finland, Iceland, Norway and Sweden; the autonomous territories of the Faroe Islands and Greenland; and the autonomous region of Åland.

Group 1035
Prix Galien Bridges Charter
Group 1037
Worldwide Committees
Group 1033
FAQ
Contact Us
PRIX GALIEN HALL OF FAME
Search the innovations that have made the greatest impact on human health over the course of the past 50 years worldwide.